Citi analyst Geoff Meacham downgraded Merck (NYSE: MRK) from Buy to Neutral with a price target of $84.00 (from $115.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE